Relafen: A New Drug with an Old Danger


Individuals who regularly take Relafen (nabumetone) or other anti-inflammatory medications, either for arthritis, joint pain, or other indications, should be aware of severe adverse health implications that can potentially result from prolonged use. Relafen is usually prescribed for osteoarthritis or rheumatoid arthritis to reduce pain, inflammation, and stiffness, but can also be prescribed for other purposes. Relafen works by reducing the level of hormones in the body that can cause pain and inflammation. In addition to the warnings provided with the packaging of the medication and those related by a physician, there are other important concerns that users of Relafen should know about.

Stevens-Johnson Syndrome is a severe allergic reaction to certain drugs. In addition to NSAIDs, antibiotics such as sulfonamides, tetracycline, amoxicillin, and ampicillin have been implicated. The symptoms of Stevens-Johnson Syndrome typically begin as some form of upper respiratory infection, including also fever, sore throat, inflammation of the mouth, chills, headaches, aching of the joints, and generally feeling ill. After onset, Stevens-Johnson Syndrome will continue to develop, affecting the various mucous membranes of the body, including the mouth, esophagus, nostrils, eyes, genitals, and anal regions. Lesions may develop and the skin may blister or even detach in severe cases.


  • On main

    [© 2015] Medicine. Site map